Zeus Capital acted as Financial Adviser to Connex Solutions in the £9.1m share sale to Belerion Capital in the Manchester based technology firm. The multimillion-pound transaction fully exits three founding ...
Read Article »INTERVIEW: Allergy Therapeutics Plc Acarovac Sales could top $500m – Zeus Capital
Allergy Therapeutics Plc (LON:AGY) is the topic of conversation with Dr Gary Waanders Director of Healthcare Research at Zeus Capital. Since Allergy Therapeutics announced today that it has obtained approval ...
Read Article »INTERVIEW: Oncimmune Holdings Plc Sales growth to come from a number of directions say Zeus Capital
Oncimmune Holdings Plc (LON:ONC) is the topic of conversation when Dr Gary Waanders the Director of Healthcare Research at Zeus Capital caught up with DirectorsTalk. Gary talks us through the ...
Read Article »INTERVIEWS: Ceres Power Holdings plc CEO Phil Caldwell & Zeus Capital Dr Tom McColm on positive trading update
Ceres Power Holdings plc (LON:CWR) CEO Phil Caldwell chats with DirectorsTalk about it’s latest trading update. Phil talks about the last 6 months, opportunities for the company, the effects of ...
Read Article »INTERVIEW: Zeus Capital Upgrade forecast for Allergy Therapeutics Plc
Allergy Therapeutics Plc (LON:AGY) is the topic of conversation when DirectorsTalk caught up with Dr Gary Waanders the Director of Healthcare Research at Zeus Capital. Gary explains whats driven growth ...
Read Article »Motif Bio Plc Get updated coverage from Zeus Capital
Motif Bio Plc (LON:MTFB) is the topic of conversation when DirectorsTalk caught up with Dr Gary Waanders the Director of Healthcare Research at Zeus Capital. Gary covers the highlights for ...
Read Article »INTERVIEW: City of London Investment Group – Now is a good time say Zeus Capital
City of London Investment Group Plc (LON:CLIG) is the topic of conversation with Robin Savage, research director at Zeus Capital. Robin explains why a 61% increase in its profit before ...
Read Article »Elegant Hotels Group Plc CEO chats & Zeus say very attractive long term investment
Elegant Hotels Group Plc (LON:EHG) is the topic of discussion with Mike Allen, head of research at Zeus Capital. Mike explains his take on the 2016 results, talks about key ...
Read Article »C4X Discovery Holdings Plc Products should attract significant large pharma interest – Zeus Capital
C4X Discovery Holdings Plc (LON:C4XD) is the topic of discussion with Dr Gary Waanders, Healthcare Research Director at Zeus Capital. Gary, runs through the important highlights from the latest results ...
Read Article »INTERVIEW: Zeus Capital Say A really important investment for Mortgage Advice Bureau (Holdings) plc
Mortgage Advice Bureau (Holdings) plc (LON:MAB1) is the topic of conversation when Zeus Capital research director caught up with DirectorsTalk. Robin explains how material is this investment of a joint ...
Read Article »